200 related articles for article (PubMed ID: 6152370)
1. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
Abonyi M; Kisfaludy S; Szalay F
Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic diseases of the liver with catergen].
Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
[TBL] [Abstract][Full Text] [Related]
4. Effects of (+)-cyanidanol-3 on chronic liver injury.
Kovách G; Salamon F
Acta Physiol Hung; 1984; 64(3-4):443-8. PubMed ID: 6152368
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
[TBL] [Abstract][Full Text] [Related]
6. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
Pár A; Paál M; Kádas I; Kerekes E; Jávor T
Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
Aguilar Reina J; de la Santa López J; Cuadras Avellana CM; Kern A
Fortschr Med; 1978 Jan; 96(2):75-9. PubMed ID: 74352
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic hepatitis patients with catergen].
Karkishchenko NN; Okorokov AN; Fedorov NE; Laktionova AA; Sidorenko LF
Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
[TBL] [Abstract][Full Text] [Related]
9. (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial.
World MJ; Aps EJ; Shaw GK; Thomson AD
Alcohol Alcohol; 1984; 19(1):23-9. PubMed ID: 6149758
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
Fehér J; Toncsev H; Sréter L; Cornides A; Kiss A
Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
[TBL] [Abstract][Full Text] [Related]
11. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
[TBL] [Abstract][Full Text] [Related]
12. Factors predictive of liver histopathological appearance in chronic alcoholic pancreatitis with common bile duct stenosis and increased serum alkaline phosphatase.
Lesur G; Levy P; Flejou JF; Belghiti J; Fekete F; Bernades P
Hepatology; 1993 Nov; 18(5):1078-81. PubMed ID: 8225211
[TBL] [Abstract][Full Text] [Related]
13. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
Traissac FJ; Borg R
Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
[No Abstract] [Full Text] [Related]
14. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
Vido I; Schmidt FW; Müller R; Ranft U; Wildhirt E; Holzer E; Wallnöfer H; Korb G
Dtsch Med Wochenschr; 1980 Mar; 105(10):330-2. PubMed ID: 6153953
[TBL] [Abstract][Full Text] [Related]
15. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
[No Abstract] [Full Text] [Related]
16. [Experiments with a new drug in chronic liver diseases, especially alcohol-induced].
Bel A; Chambon A
Minerva Dietol Gastroenterol; 1977; 23(3):243-8. PubMed ID: 372846
[No Abstract] [Full Text] [Related]
17. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
Sondern W; Leube G
Med Klin; 1978 Oct; 73(41):1432-6. PubMed ID: 703670
[TBL] [Abstract][Full Text] [Related]
18. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
Spech HJ; Liehr H; Mitschke H
Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
[No Abstract] [Full Text] [Related]
20. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
